AnGes Inc - Company Profile
Powered by 
All the sales intelligence you need on AnGes Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how AnGes Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with AnGes Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on AnGes Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022262623A1 | Application | Novel omni 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 and 262 crispr nucleases | C12N9/22 | November 30, 2023 |
| US20230383273A1 | Application | Novel omni 56, 58, 65, 68, 71, 75, 78, and 84 crispr nucleases | C12N15/11; C12N15/907; C12N2310/20; C12N2800/80; C12N9/22 | November 30, 2023 |
| EP4096684A4 | Search Report | Verfahren und zusammensetzungen zur verlängerten entzündungshemmung und/oder verlängerte behandlung von rückenschmerzen mit chimären-decoy | C12N2310/13; C12N2310/315; C12N2310/51; C12N2310/531; A61K31/713; A61P19/04 | November 22, 2023 |
| AU2022245996A9 | Application | Compositions and methods for treating hypercholesterolemia | C12N15/1138; C12N15/907; C12N2310/20; C12N9/22; C07K14/705 | November 09, 2023 |
| AU2022245996A1 | Application | Compositions and methods for treating hypercholesterolemia | C12N15/1138; C12N15/907; C12N2310/20; C12N9/22; C07K14/705 | November 02, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer